Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 2.21 ($0.03) and last traded at GBX 3 ($0.04), with a volume of 579069 shares traded. The stock had previously closed at GBX 6.12 ($0.08).
Celadon Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 196.67, a current ratio of 1.92 and a quick ratio of 6.97. The stock has a 50 day simple moving average of GBX 16.90 and a two-hundred day simple moving average of GBX 21.21. The company has a market cap of £1.84 million, a price-to-earnings ratio of -0.38 and a beta of -0.26.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Top Biotech Stocks: Exploring Innovation Opportunities
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Stock Dividend Cuts Happen Are You Ready?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
